|
HMGN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70996550252767E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.10462807976364E-15 |
| Normal-vs-Stage2 |
8.697100E-03 |
| Normal-vs-Stage3 |
2.175500E-04 |
| Normal-vs-Stage4 |
2.28759999998385E-06 |
| Stage1-vs-Stage2 |
2.551800E-02 |
| Stage1-vs-Stage3 |
1.902420E-01 |
| Stage1-vs-Stage4 |
6.205400E-01 |
| Stage2-vs-Stage3 |
4.327600E-01 |
| Stage2-vs-Stage4 |
1.500630E-01 |
| Stage3-vs-Stage4 |
4.907600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66033853332692E-12 |
| Normal-vs-AfricanAmerican |
1.706400E-02 |
| Normal-vs-Asian |
1.857030E-01 |
| Caucasian-vs-AfricanAmerican |
6.793600E-02 |
| Caucasian-vs-Asian |
7.632400E-01 |
| AfricanAmerican-vs-Asian |
6.614600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09099951295377E-10 |
| Normal-vs-Female |
2.09832151654155E-12 |
| Male-vs-Female |
2.358800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.557200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.83869635867518E-11 |
| Normal-vs-Age(61-80Yrs) |
1.34850020039323E-10 |
| Normal-vs-Age(81-100Yrs) |
4.767700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.030400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.684600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.719400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.762800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.584600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.596000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.584500E-04 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
3.24610000002057E-06 |
| Normal-vs-Grade 4 |
3.259600E-02 |
| Grade 1-vs-Grade 2 |
3.920000E-01 |
| Grade 1-vs-Grade 3 |
4.930200E-02 |
| Grade 1-vs-Grade 4 |
2.374300E-02 |
| Grade 2-vs-Grade 3 |
1.209870E-04 |
| Grade 2-vs-Grade 4 |
4.550800E-04 |
| Grade 3-vs-Grade 4 |
3.608600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
2.969800E-02 |
| ccA subtype-vs-ccB subtype |
1.85579995815033E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11869990837965E-10 |
| Normal-vs-N1 |
2.407200E-01 |
| N0-vs-N1 |
1.552210E-02 |
|
|
